143 related articles for article (PubMed ID: 37307529)
21. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus.
Nayna L; Emma W; Vani K
Curr Opin Gastroenterol; 2016 Jul; 32(4):294-301. PubMed ID: 27070914
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.
Wani S; Falk GW; Post J; Yerian L; Hall M; Wang A; Gupta N; Gaddam S; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Goldblum J; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2011 Oct; 141(4):1179-86, 1186.e1. PubMed ID: 21723218
[TBL] [Abstract][Full Text] [Related]
24. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
25. Barrett's esophagus, towards improved clinical practice.
Martínez-Domínguez SJ; Lanas Á; Domper-Arnal MJ
Med Clin (Barc); 2022 Jul; 159(2):92-100. PubMed ID: 35606193
[TBL] [Abstract][Full Text] [Related]
26. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma.
Cotton CC; Eluri S; Shaheen NJ
Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106
[TBL] [Abstract][Full Text] [Related]
27. Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus.
Vennalaganti P; Kanakadandi V; Goldblum JR; Mathur SC; Patil DT; Offerhaus GJ; Meijer SL; Vieth M; Odze RD; Shreyas S; Parasa S; Gupta N; Repici A; Bansal A; Mohammad T; Sharma P
Gastroenterology; 2017 Feb; 152(3):564-570.e4. PubMed ID: 27818167
[TBL] [Abstract][Full Text] [Related]
28. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
29. Not all low grade dysplasia in Barrett's oesophagus is the same: using specific histological criteria in predicting progression to neoplasia.
Tsoi EH; Williams RA; Christie M; Machet D; Deb S; Sundararajan V; Cameron GR; Desmond PV; Taylor ACF
Pathology; 2021 Oct; 53(6):700-704. PubMed ID: 34420794
[TBL] [Abstract][Full Text] [Related]
30. Barrett's esophagus and Barrett's carcinoma.
von Rahden BH; Stein HJ; Siewert JR
Curr Oncol Rep; 2003 May; 5(3):203-9. PubMed ID: 12667417
[TBL] [Abstract][Full Text] [Related]
31. Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression.
Klaver E; Bureo Gonzalez A; Mostafavi N; Mallant-Hent R; Duits LC; Baak B; Böhmer CJM; van Oijen AHAM; Naber T; Scholten P; Meijer SL; Bergman JJGHM; Pouw RE;
United European Gastroenterol J; 2021 Oct; 9(8):929-937. PubMed ID: 34228885
[TBL] [Abstract][Full Text] [Related]
32. [New developments for endoscopic management of Barrett's esophagus with high grade dysplasia].
Wang RH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 39(5):534-41. PubMed ID: 20936731
[TBL] [Abstract][Full Text] [Related]
33. Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis.
Frei NF; Konte K; Bossart EA; Stebbins K; Zhang Y; Pouw RE; Critchley-Thorne RJ; Bergman JJGHM
Clin Transl Gastroenterol; 2020 Oct; 11(10):e00244. PubMed ID: 33108124
[TBL] [Abstract][Full Text] [Related]
34. Dysplasia in Random Biopsies from Barrett's Surveillance Is an Important Marker for More Severe Pathology.
Noordzij IC; Van Loon van de Ende MCM; Curvers WL; van Lijnschoten G; Huysentruyt CJ; Schoon EJ
Dig Dis Sci; 2021 Jun; 66(6):1957-1964. PubMed ID: 32661766
[TBL] [Abstract][Full Text] [Related]
35. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.
Curvers WL; ten Kate FJ; Krishnadath KK; Visser M; Elzer B; Baak LC; Bohmer C; Mallant-Hent RC; van Oijen A; Naber AH; Scholten P; Busch OR; Blaauwgeers HG; Meijer GA; Bergman JJ
Am J Gastroenterol; 2010 Jul; 105(7):1523-30. PubMed ID: 20461069
[TBL] [Abstract][Full Text] [Related]
36. Impact of expert center endoscopic assessment of confirmed low grade dysplasia in Barrett's esophagus diagnosed in community hospitals.
Nieuwenhuis EA; van Munster SN; Curvers WL; Weusten BLAM; Alvarez Herrero L; Bogte A; Alkhalaf A; Schenk BE; Koch AD; Spaander MCW; Tang TJ; Nagengast WB; Westerhof J; Houben MHMG; Bergman JJGHM; Schoon EJ; Pouw RE;
Endoscopy; 2022 Oct; 54(10):936-944. PubMed ID: 35098524
[TBL] [Abstract][Full Text] [Related]
37. Management strategies of Barrett's esophagus.
De Palma GD
World J Gastroenterol; 2012 Nov; 18(43):6216-25. PubMed ID: 23180941
[TBL] [Abstract][Full Text] [Related]
38. Analysis of dysplasia in patients with Barrett's esophagus based on expression pattern of 90 genes.
Varghese S; Newton R; Ross-Innes CS; Lao-Sirieix P; Krishnadath KK; O'Donovan M; Novelli M; Wernisch L; Bergman J; Fitzgerald RC
Gastroenterology; 2015 Nov; 149(6):1511-1518.e5. PubMed ID: 26248086
[TBL] [Abstract][Full Text] [Related]
39. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma.
Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL
J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044
[TBL] [Abstract][Full Text] [Related]
40. Clinical pathways and outcomes of patients with Barrett's esophagus in tertiary care settings: a prospective longitudinal cohort study in Australia, 2008-2016.
Na R; Miura K; O'Brien S; Eslick GD; Kendall BJ; Hourigan LF; Bourke M; Cox MR; Farrokhzadi L; Levert-Mignon AJ; Barbour AP; Clemons NJ; Duong CP; Lord RV; Phillips WA; Watson DI; Whiteman DC
Dis Esophagus; 2021 Aug; 34(8):. PubMed ID: 33306781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
